Kaletra
Product Images NDC 21695-362

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Kaletra (NDC 21695-362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Body Surface Area Equation. (20f8c35b Bf1c 44cf Bdd7 01b56b85bc0c 01)

FDA Label Image

Chemical Structure For Lopinavir. (20f8c35b Bf1c 44cf Bdd7 01b56b85bc0c 02)

FDA Label Image

Chemical Structure For Ritonavir. (20f8c35b Bf1c 44cf Bdd7 01b56b85bc0c 03)

FDA Label Image

Figure Displays Steady-state Plasma Concentrations For Lopinavir And Ritonavir. (20f8c35b Bf1c 44cf Bdd7 01b56b85bc0c 04)

Figure Displays Steady-state Plasma Concentrations For Lopinavir And Ritonavir. (20f8c35b Bf1c 44cf Bdd7 01b56b85bc0c 04)
This appears to be a data table with concentration levels of Lopinavir and Ritonavir at different time intervals in hours. The concentration values are given in ug/mL, and there is a 95% confidence level mentioned for one of the drugs.*
FDA Label Image

Kaletra 200mg/50mg (20f8c35b Bf1c 44cf Bdd7 01b56b85bc0c 05)

Kaletra 200mg/50mg (20f8c35b Bf1c 44cf Bdd7 01b56b85bc0c 05)
This appears to be a medication label. Each tablet contains 200mg Lopinavir and 50mg Ritonavir. The product is from Aeron Pharmaceuticals. The label also includes a warning about medications that should not be taken with Kalers. The rest of the text is not clear due to errors in .*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.